National Research (NASDAQ:NRC) Hits New 52-Week Low at $33.01

Shares of National Research Co. (NASDAQ:NRC) hit a new 52-week low during trading on Thursday . The company traded as low as $33.01 and last traded at $33.01, with a volume of 1052 shares traded. The stock had previously closed at $33.32.

Analyst Ratings Changes

Separately, TheStreet lowered shares of National Research from a “b-” rating to a “c+” rating in a research report on Thursday, January 11th.

National Research Stock Performance

The firm has a market cap of $811.62 million, a P/E ratio of 27.22 and a beta of 0.42. The stock’s 50-day moving average price is $38.57 and its 200 day moving average price is $40.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. The business had revenue of $38.00 million for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a yield of 1.41%. National Research’s payout ratio is 38.40%.

Hedge Funds Weigh In On National Research

Institutional investors have recently added to or reduced their stakes in the company. Qube Research & Technologies Ltd acquired a new position in National Research during the third quarter worth $45,000. Lazard Asset Management LLC acquired a new position in shares of National Research in the first quarter valued at $49,000. Gladius Capital Management LP increased its holdings in shares of National Research by 59.8% in the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after purchasing an additional 496 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of National Research by 675.3% in the first quarter. Tower Research Capital LLC TRC now owns 1,349 shares of the company’s stock valued at $59,000 after purchasing an additional 1,175 shares during the last quarter. Finally, State of Wyoming increased its holdings in shares of National Research by 154.0% in the second quarter. State of Wyoming now owns 1,722 shares of the company’s stock valued at $75,000 after purchasing an additional 1,044 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors and hedge funds.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.